TX Bio ABI-3900 PMA

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Centers for Disease Control and Prevention (CDC) The Biotechnology Core Facility Branch (BCFB) within the Division of Core Laboratory and Scientific Resources (DCLSR) intends to award a firm fixed price purchase order to TX BIO LC. 9 Century Ct Trophy Club, TX 76262. Under the authority of FAR 13.106-1(b)(1)(i), only one responsible source and no other supplies or services will satisfy agency requirements. The purpose of this procurement is for annual preventative maintenance services on the ABI 3900 synthesizer laboratory equipment.

The contractor shall perform preventative maintenance and repairs for the following system:

ABI-3900 synthesizer, serial number 10245

SECTION 4 – TASKS TO BE PERFORMED

The contractor shall:

1. Perform equipment maintenance services and repairs on the ABI 3900 Synthesizer
2. Provide all labor, travel, and parts with unlimited breakdown calls
3. Perform one scheduled preventative maintenance visit per year which includes a full system diagnostic using software and critical parts exchanged
4. Priority response for all breakdown calls

TX BIO LC is the service company for the ABI 3900 DNA synthesizer and has the knowledge and

experience to do so. They also have a 24 – 48 hour response time and their service engineers have

experience with this DNA synthesizer.

-Service engineers have ABI 3900 instrument repair training

-Minimum of 12 years of field service experience on the instrument

-Use Genuine OEM parts

This is the only contractor identified with trained service engineers and a proven track record in

maintaining and repairing the ABI 3900 DNA Synthesizer, and therefore, has the capability to

respond and meet our service requirements.

The anticipated award date of this action is on or before Aug, 01, 2026. The applicable NAICS code is 811210 Electronic and Precision Equipment Repair and Maintenance. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the warranties and proof as being an authorized distributor of the product. Capability statements shall not exceed  2 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 12:00 PM Eastern Standard Time (EST), July 22, 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to Javier Aponte email address at: zsm9@cdc.gov NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.